AI Summary
Thinking
Thinking
We reviewed 12 live results for ophthalmic oncology and narrowed them down to the 3 options that look most worth comparing first.
The options are Ophthalmic Genetics, Cyclosporine 1% Oil Ophthalmic Solution and Champions Oncology.
Source: Acibadem Hospitals Group
Description
Ophthalmic genetics at Acibadem Hospitals Group is a comprehensive diagnostic service evaluating inherited eye diseases such as retinitis pigmentosa, Stargardt disease, and optic neuropathies. Delivered by experienced ophthalmologists and medical genetics specialists across accredited hospitals in Turkey, the service integrates specialist clinical examinations, advanced retinal imaging, and targeted gene panel or sequencing tests. The outpatient evaluation takes one to two hours, establishing accurate molecular diagnoses to guide surveillance, identify syndromic risks, and provide actionable family counseling.
Best for
Patients with unexplained vision loss or early-onset eye conditions, Families with a history of inherited retinal or optic nerve disorders, Evaluating inherited retinal dystrophies and optic neuropathies and Clarifying genetic inheritance patterns and family recurrence risks
Rate this product
Source: New Drug Loft and VLS Pharmacy
Description
Cyclosporine 1% Oil Ophthalmic Solution by New Drug Loft and VLS Pharmacy is a prescription compounded topical medication supplied in a 5mL volume. Classed as an immunomodulator, this sterile solution is commonly prescribed as a tear supplement for the treatment of dry eye disease. It is exclusively compounded for ophthalmic use within a sterile compounding facility adhering to USP <795>, <797>, and <800> compliance standards, requiring a valid patient-specific prescription.
Best for
Patients with dry eye and Treatment of dry eye disease as a tear supplement
Rate this product
Source: Unknown source
Description
Champions Oncology is an oncology contract research and biotechnology organization providing preclinical research, clinical specialty testing, and histopathology services. The company offers end-to-end histology sample preparation, custom immunohistochemistry (IHC) assay development, tissue microarray (TMA) generation from TumorGraft PDX models, advanced microscopic imaging, and specialized scoring by board-certified pathologists. Champions Oncology maintains GCLP-compliant laboratory operations to deliver high-quality quantitative biomarker analysis and target expression evaluation supporting pharmaceutical drug discovery and clinical trials.
Best for
biopharmaceutical companies, oncology drug developers, preclinical histology and IHC testing and target expression evaluation
Rate this product
| Compare | #1Ophthalmic Genetics | #2Cyclosporine 1% Oil Ophthalmic Solution | #3Champions Oncology |
|---|---|---|---|
| Source | Acibadem Hospitals Group | New Drug Loft and VLS Pharmacy | Unknown source |
| Description | Ophthalmic genetics at Acibadem Hospitals Group is a comprehensive diagnostic service evaluating inherited eye diseases such as retinitis pigmentosa, Stargardt disease, and optic neuropathies. Delivered by experienced ophthalmologists and medical genetics specialists across accredited hospitals in Turkey, the service integrates specialist clinical examinations, advanced retinal imaging, and targeted gene panel or sequencing tests. The outpatient evaluation takes one to two hours, establishing accurate molecular diagnoses to guide surveillance, identify syndromic risks, and provide actionable family counseling. | Cyclosporine 1% Oil Ophthalmic Solution by New Drug Loft and VLS Pharmacy is a prescription compounded topical medication supplied in a 5mL volume. Classed as an immunomodulator, this sterile solution is commonly prescribed as a tear supplement for the treatment of dry eye disease. It is exclusively compounded for ophthalmic use within a sterile compounding facility adhering to USP <795>, <797>, and <800> compliance standards, requiring a valid patient-specific prescription. | Champions Oncology is an oncology contract research and biotechnology organization providing preclinical research, clinical specialty testing, and histopathology services. The company offers end-to-end histology sample preparation, custom immunohistochemistry (IHC) assay development, tissue microarray (TMA) generation from TumorGraft PDX models, advanced microscopic imaging, and specialized scoring by board-certified pathologists. Champions Oncology maintains GCLP-compliant laboratory operations to deliver high-quality quantitative biomarker analysis and target expression evaluation supporting pharmaceutical drug discovery and clinical trials. |
| Best for | Patients with unexplained vision loss or early-onset eye conditions, Families with a history of inherited retinal or optic nerve disorders, Evaluating inherited retinal dystrophies and optic neuropathies and Clarifying genetic inheritance patterns and family recurrence risks | Patients with dry eye and Treatment of dry eye disease as a tear supplement | biopharmaceutical companies, oncology drug developers, preclinical histology and IHC testing and target expression evaluation |
| Action | Acibadem Hospitals Group | New Drug Loft and VLS Pharmacy | Champions Oncology |
| Rate this product |
"Ophthalmic Genetics from Acibadem Hospitals Group."
Note: TopFind AI compiles product and service information for general comparison purposes only.
